by Ali | Nov 13, 2021 | Members Only |
Managing post COVID long term symptoms with cannabinoid therapy Clinicians are invited to join the Medical Cannabis Clinicians Society and BOD Australia to explore the role of cannabinoid therapy in managing Long COVID symptoms. A significant number of patients with...
by Ali | Nov 13, 2021 | Patients |
With anxiety becoming more prevalent in the last year as a result of the global pandemic and lockdown restrictions, there’s growing curiosity in THC. But as this cannabis scientist explains, it’s important to do your research first. Click here for the full...
by Ali | Oct 15, 2021 | Doctors Only |
Objectives To assess the tolerability and effectiveness of the Entoura THC10 : CBD15 medicinal cannabis oil on sleep in adults with insomnia in a randomised cross-over double-blind placebo-controlled 6-week trial. Background Insomnia or difficulty falling or staying...
by Ali | Oct 6, 2021 | Patients |
Lifespot Health rebrands to InhaleRx, pushes development of Medihale inhaler Australian medicinal cannabis device company Lifespot Health (ASX: LSH) has officially changed its name to InhaleRx (ASX: IRX), with the change to take effect on Wednesday. It utilises heat...
by Ali | Oct 6, 2021 | Patients |
Medical cannabis therapy is associated with a reduction in the use of prescription opioids among chronic pain patients, according to recent data published in the journal BMJ Supportive & Palliative Care. This could be an important development in terms of pain...
